Troponin in Heart Failure
Kevin S Shah1, Alan S Maisel2, Gregg C Fonarow3
1University of California, Los Angeles, 650 Charles E. Young Drive South, A2-237 CHS, MC: 167917, Los Angeles, CA 90095, USA.
Heart Failure Clinics
|November 21, 2017
Summary
Cardiac troponin is a key biomarker for acute coronary syndrome and heart failure (HF). Advancements in high-sensitivity troponin assays increase detectable levels in HF patients, offering new therapeutic targets.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Research
Background:
- Cardiac troponin is crucial for diagnosing acute coronary syndrome.
- Troponin also serves as a prognostic marker in acute and chronic heart failure (HF).
- Increasing assay sensitivity leads to more detectable troponin in HF patients.
Purpose of the Study:
- To review the current literature on troponin's value in managing heart failure patients.
- To explore the potential of troponin as a future therapeutic target in HF.
Main Methods:
- Literature review of existing studies on cardiac troponin in heart failure.
- Analysis of the implications of high-sensitivity troponin assays.
Main Results:
- Elevated troponin levels in HF are associated with prognosis.
- High-sensitivity assays detect troponin more frequently in HF patients.
- Troponin's role in HF management is expanding.
Conclusions:
- Cardiac troponin is increasingly important in heart failure management.
- Future strategies may target troponin for novel HF therapies.
- High-sensitivity troponin assays enhance prognostic capabilities in HF.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
942
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
942
01:30Acute Coronary Syndrome III: Diagnostic Studies
309
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
01:26Heart Failure Drugs: Inotropic Agents
1.6K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:22Heart Failure Drugs: β-Blockers
986
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
986